Role of T cells in cancer immunotherapy: Opportunities and challenges
Cancer Pathogenesis and Therapy · 2023-04 · 1 (2) · 116-126
DOI: 10.1016/j.cpt.2022.12.002 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Pathogenesis and Therapy, 2023-04. Verfasst von Hossain Ahmed und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology and Genetic Engineering, University of Development Alternative (UODA), 4/4B, Block A, Lalmatia, Dhaka, 1209, Bangladesh. Die Arbeit wurde bisher 136-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Immunotherapies boosting the immune system's ability to target cancer cells are promising for the treatment of various tumor types, yet clinical responses differ among patients and cancers. Recently, there has been increasing interest in novel cancer immunotherapy practices aimed at triggering T cell-mediated anti-tumor responses. Antigen-directed cytotoxicity mediated by T lymphocytes has become a central focal point in the battle against cancer utilizing the immune system. The molecular and cellular mechanisms involved in the actions of T lymphocytes have directed new therapeutic approaches in cancer immunotherapy, including checkpoint blockade, adoptive and chimeric antigen receptor (CAR) T cell therapy, and cancer vaccinology. This review addresses all the strategies targeting tumor pathogenesis, including metabolic pathways, to evaluate the clinical significance of current and future immunotherapies for patients with cancer, which are further engaged in T cell activation, differentiation, and response against tumors.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biotechnology and Genetic Engineering, University of Development Alternative (UODA), 4/4B, Block A, Lalmatia, Dhaka, 1209, Bangladesh.
- Department of Biochemistry and Molecular Biology, Mawlana Bhashani Science and Technology University, Tangail, 1902, Bangladesh.
- Department of Biochemistry and Molecular Biology, Faculty of Biological Science, University of Dhaka, Dhaka, 1000, Bangladesh.
- Department of Immunology and Microbiology, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX, 78504, USA.
- Department of Genetic Engineering and Biotechnology, Faculty of Biological Science and Technology, Jashore University of Science and Technology (JUST), Jashore, 7408, Bangladesh.
- Department of Biochemistry and Microbiology, North South University, Dhaka, 1229, Bangladesh.
Zitieren
APA
Ahmed, H., Mahmud, A. R., Siddiquee, M. F., Shahriar, A., Biswas, P., Shimul, M. E. K., Ahmed, S. Z., Ema, T. I., Rahman, N., Khan, M. A., Mizan, M. F. R., & Emran, T. B. (2023). Role of T cells in cancer immunotherapy: Opportunities and challenges. Cancer Pathogenesis and Therapy, 1(2), 116-126. https://doi.org/10.1016/j.cpt.2022.12.002
Vancouver
Ahmed H, Mahmud AR, Siddiquee MF, Shahriar A, Biswas P, Shimul MEK, et al. Role of T cells in cancer immunotherapy: Opportunities and challenges. Cancer Pathogenesis and Therapy. 2023;1(2):116-126. doi:10.1016/j.cpt.2022.12.002
BibTeX
@article{Ahmed2023,
author = {Ahmed, Hossain and Mahmud, Aar Rafi and Siddiquee, Mohd Faijanur-Rob- and Shahriar, Asif and Biswas, Partha and Shimul, Md Ebrahim Khalil and Ahmed, Shahlaa Zernaz and Ema, Tanzila Ismail and Rahman, Nova and Khan, Md Arif and Mizan, Md Furkanur Rahaman and Emran, Talha Bin},
title = {Role of T cells in cancer immunotherapy: Opportunities and challenges},
journal = {Cancer Pathogenesis and Therapy},
year = {2023},
volume = {1},
number = {2},
pages = {116--126},
doi = {10.1016/j.cpt.2022.12.002}
}
EUVIMED